- A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO STUDY THEVIASKIN® PEANUT’S EFFICACY AND SAFETY FOR TREATING PEANUT ALLERGY IN CHILDREN AND ADULTS (VIPES STUDY)
Peanut Oral Immunotherapy
The Food Allergy Center of MGH is conducting a research study examining the effectiveness of an investigational medication called Viaskin® Peanut in the treatment of peanut allergy.
Subjects needed:
Individuals between the ages 6-55 years who have been diagnosed with a peanut allergy by a positive skin prick test and positive blood test for peanut and a well-documented medical history of systemic reactions after ingestion of peanut. Individuals must also be currently following a strict peanut-free diet. The study requires 12 visits to Massachusetts General Hospital. During these visits you/your child would undergo physical exams, blood tests, skin prick tests, Viaskin® Peanut patch administration, and food challenges. The medicine patch will be worn each day as a potential treatment for peanut allergy. The research study will last up to 12 months. Parking expenses will be reimbursed and your time will be compensated.
For more information, please call 617-643-5952 or email tswenson@partners.org.
The Food Allergy Center of MGH is conducting a research study examining the effectiveness of an investigational medication called Viaskin® Peanut in the treatment of peanut allergy.
Subjects needed:
Individuals between the ages 6-55 years who have been diagnosed with a peanut allergy by a positive skin prick test and positive blood test for peanut and a well-documented medical history of systemic reactions after ingestion of peanut. Individuals must also be currently following a strict peanut-free diet. The study requires 12 visits to Massachusetts General Hospital. During these visits you/your child would undergo physical exams, blood tests, skin prick tests, Viaskin® Peanut patch administration, and food challenges. The medicine patch will be worn each day as a potential treatment for peanut allergy. The research study will last up to 12 months. Parking expenses will be reimbursed and your time will be compensated.
For more information, please call 617-643-5952 or email tswenson@partners.org.
Institution – MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator – Wayne G Shreffler, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – Theadora Swenson
Email – foodallergy@mgh.harvard.edu
Phone – 617-643-5952
